- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04807387
Newly Designed Vaginal Stent to Improve Patient Comfort and Healing Following Vaginal Surgery or Vaginal Radiation
Newly-designed Vaginal Stent to Improve Tissue Healing for Girls and Women With Congenital and Reproductive Anomalies
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
After surgery or radiation to the vaginal area, a common patient risk is that their vaginal tissue sticks together and scars. This can cause the vaginal canal to narrow or shorten. This can occur in up to 73% of patients and to fix the scarring, more surgery or uncomfortable procedures may be needed to widen the canal. To prevent the problem of scarring after surgery or radiation, patients should wear a stent to hold open the vaginal canal. Unfortunately, the current stents are poorly made and not very advanced. The result can be a poor fit to the vagina, movement of the stent, and patients not being able to wear the stent for a long enough time to keep the vaginal tissue from scarring.
The first aim of this trial is for healthy participants to evaluate two newly designed stents. Each participant will have a stent placed for 24 hours, removed for 24 hours, and the second stent placed for 24 hours. The participants will evaluate the stent on comfort (during insertion, wearing, and removal), retention, any impact on daily functions, and chose which stent performed better overall. That stent will then be placed in the healthy participants for 2 weeks of continuous wear. Participants will answer daily questionnaires on comfort, retention, and any adverse effects. Physicians will also be asked to complete questionnaires at each appointment related to stent performance.
The second aim of the trial is for two different patient populations to evaluate the preferred stent chosen by the healthy participants. Adolescent girls undergoing vaginal reconstructive surgery for vaginal anomalies will have a stent placed following surgery. During the two weeks of continuous wear, participants will be asked to answer daily questionnaires on comfort, retention, and adverse effects. The stent will be removed at two weeks, and participants will be asked to complete a follow-up questionnaire at each of their standard of care appointments, 2, 4, and 6 weeks, 3, 6, and 12 months. Adult females undergoing vaginal brachytherapy will have a stent placed after their last brachytherapy treatment. The participants will wear the stent continuously for 2 weeks and be asked to answer daily questionnaires on comfort, retention, and adverse effects. Participants will have a 2-week follow-up, during which the stent will be removed, they will be examined, and the stent will be replaced for 2 more weeks of continuous wear. At the 4-week follow-up, the stent will be removed and subsequent standard of care follow-ups will continue at 3, 6, and 12 months. Physicians will also be asked to complete questionnaires at each appointment related to stent performance.
During all phases of the trial, the data safety monitoring board will meet at regularly scheduled meetings and immediately after any severe or unanticipated adverse event. After our 12 months of follow up, data collected from both participant and physician questionnaires will be analyzed by the study bio-statistician and compared to retrospective data.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Baylor College of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria (healthy participants):
- Not pregnant
- participant consent or parent/guardian consent & participant assent
- Understand requirements of study
- Agree to abide by study restrictions
- Able to travel to Houston
- Understand English or Spanish to a 5th grade level
- No prior history of vaginal surgery or radiation
Inclusion Criteria (pediatric participants):
- Not pregnant
- participant consent or parent/guardian consent & participant assent
- Understand requirements of study
- Agree to abide by study restrictions
- Able to travel to Houston
- Understand English or Spanish to a 5th grade level
- Undergoing vaginal surgery
Inclusion Criteria (adult radiation participants):
- Not pregnant
- participant consent or parent/guardian consent & participant assent
- Understand requirements of study
- Agree to abide by study restrictions
- Able to travel to Houston
- Understand English or Spanish to a 5th grade level
- Undergoing vaginal brachytherapy
Exclusion Criteria (all arms):
- Non-English or Spanish speaker
- Pregnant
- BMI > 45
- Diabetic neuropathy limiting use of hands
- Other limited mobility of hands
- Vaginismus
- Urinary retention
- Vaginal bacterial infection
- Vaginal fungal infection
- Allergies to stent materials
- Seizure disorder
- Pain with sexual intercourse or tampon insertion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Healthy participants: acute
Healthy participants will wear one of two vaginal stents for 24 hours, followed by a 24 hour wash out period.
They will then wear the second vaginal stent for 24 hours.
After both stents have been worn, the participants will choose the most comfortable stent.
|
Ring stent
Flower stent
|
Experimental: Healthy participants: chronic
Healthy participants will wear the stent chosen to be the more comfortable for 2 weeks without removal.
|
Vaginal stent chosen from A or B that is the most comfortable
|
Experimental: Pediatric participants: post vaginal surgery
Pediatric participants will wear the vaginal stent for 2 weeks after undergoing vaginal surgery.
|
Vaginal stent chosen from A or B that is the most comfortable
|
Experimental: Adult participants: post vaginal brachytherapy
Adult participants undergoing vaginal brachytherapy for cancer treatment will wear the stent for 2 weeks, be evaluated by a physician, and wear the stent for an additional 2 weeks.
|
Vaginal stent chosen from A or B that is the most comfortable
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants reporting vaginal stent as comfortable.
Time Frame: 24 hours - 4 weeks from stent placement
|
Participants will report daily on stent comfort and any disruption to normal daily activities.
|
24 hours - 4 weeks from stent placement
|
Number of participants able to retain vaginal stent
Time Frame: 24 hours - 4 weeks from stent placement
|
Participants will report daily if stent is retained in vaginal canal.
|
24 hours - 4 weeks from stent placement
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants who develop vaginal stenosis
Time Frame: 1 year from stent placement
|
Using retrospective data, will compare to the number of enrolled subjects that develop vaginal stenosis
|
1 year from stent placement
|
Number of required subsequent medical interventions
Time Frame: 1 year from stent placement
|
Retrospective study evaluating if requirement of additional medical interventions (i.e.
vaginal dilation, corrective surgery, etc) were changed with stent use.
|
1 year from stent placement
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Julie CE Hakim, MD, Baylor College of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-45549
- 5R44HD092156-03 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaginal Stricture
-
University of California, San DiegoNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingVaginal Stenosis | Vaginal StrictureUnited States
-
Federal University of São PauloUnknownEsophageal Stricture | Caustic Esophageal Stricture | Peptic Esophageal Stricture | Post-Surgical Esophageal StrictureBrazil
-
University of Southern CaliforniaUnknownEsophageal Stricture | Duodenal Stricture | Jejunal Stricture | Anastomotic Stricture of Small IntestineUnited States
-
Cairo UniversityTheodor Bilharz Research Institute; National Hepatology & Tropical Medicine...UnknownCholangitis | Biliary Stricture | Bile Duct Injury | Bile Duct Stricture | Benign Biliary StrictureEgypt
-
Rigshospitalet, DenmarkCompleted
-
Al-Azhar UniversityRecruiting
-
Peking University People's HospitalRecruiting
-
Stanford UniversityCompletedBiliary StrictureUnited States
-
The Cleveland ClinicCompletedBiliary StrictureUnited States
Clinical Trials on Vaginal Stent A
-
Beijing Tiantan HospitalUnknown
-
Assistance Publique Hopitaux De MarseilleTerminatedCervical Intraepithelial NeoplasiaFrance
-
Central Hospital, Nancy, FranceNot yet recruitingEach Endoscopic Intervention Using X-raysFrance
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompletedDysfunction of the Prosthetic Conduct | Lesions of the Right Ventricular Outflow TractFrance
-
Unity Health TorontoTerminated
-
Queen Mary University of LondonCompleted
-
Ankara Training and Research HospitalNot yet recruitingKidney Stone | Ureter Obstruction | Stent ComplicationTurkey
-
Meir Medical CenterUnknown
-
Grupo Espanol de Trabajo en Enfermedad de Crohn...UnknownCrohn's Disease | Chronic Inflammation | StenosisSpain
-
mohamed abosenaAin Shams UniversityCompletedLabor Onset and Length AbnormalitiesEgypt